A new study adds to the growing body of evidence suggesting psilocybin, a hallucinogenic compound found in certain mushroom species, could potentially revolutionize the treatment of depression and substance addiction. Researchers focused on the molecular interactions of psilocybin in the brain. The findings may help with designing new drugs that can treat a range of mental health disorders.
